Krka sales in Romania up 21 pct in 2014

Slovenian pharmaceutical group Krka sales in Romania increased by 21 percent last year to EUR 61.2 million against 2013, amount representing 40 percent of the company’s sales in Southeastern Europe, according to Mediafax.

Romania is the group’s largest market in Southeastern Europe, region that includes Bulgaria, Croatia, Serbia, Macedonia, Albania, Montenegro, Kosovo and Bosnia-Herzegovina.

Krka portfolio in Romania includes prescription drugs (Atoris, Roswera, Prenessa, Tolura, Karbis, Enap), over-the-counter drugs (Nalgesin/ Naldorex, Daleron, Herbion, Pikovit and Septolete) and veterinary products.

In the region, Krka sold drugs amounting to EUR 155.3 million, representing 13 percent of the EUR 1.19 billion global sales.

According to the Pharma & Hospital Report conducted by Cegedim in 2014, Krka ranks 10 on the Romanian pharmaceutical market with a market share of 3 percent.

Read more about

Alexandrion Group is looking for a suitable location in Japan to build a distillery that will produce Japanese single malt whisky

read more

Krka produces generic drugs sold in over 70 countries worldwide. The company has production facilities in Slovenia, Poland, Russia, Croatia and Germany.

Staff